U.S. Resumes Giving Johnson And Johnson Vaccine With Warning

The video discusses the addition of a warning label to the COVID-19 vaccine due to rare blood clot concerns. The vaccine was paused for 11 days, but the CDC and FDA decided to resume its use, citing that the benefits outweigh the risks. The decision followed a thorough review by medical and scientific teams. The video also highlights that 15 women developed blood clots, with three fatalities, out of nearly 8 million Johnson and Johnson vaccine recipients.

Why was the Johnson & Johnson COVID-19 vaccine paused?

• High production costs

• Ineffectiveness against new variants

• Concerns about rare blood clots

• Due to a shortage of doses

What was the conclusion of the CDC and FDA regarding the Johnson & Johnson vaccine?

• The vaccine should be reformulated

• The vaccine should be limited to older adults

• The vaccine should be discontinued

• The vaccine's benefits outweigh the risks

How many women developed blood clots after receiving the Johnson & Johnson vaccine?

• 10

• 15

• 25

• 20

What age group was primarily affected by the blood clots?

• 49 to 65

• Over 65

• Under 18

• 18 to 48

Approximately how many people have received the Johnson & Johnson vaccine?

• 8 million

• 7 million

• 6 million

• 5 million